What evidence supports the use of ivermectin in cancer treatment, and how is the quality of this evidence rated?

Ivermectin demonstrates potential anticancer properties in preclinical models, but current evidence is insufficient for its use in clinical oncology due to the lack of robust human trials and translational research.